Literature DB >> 25286864

Gene module based regulator inference identifying miR-139 as a tumor suppressor in colorectal cancer.

Jin Gu1, Yang Chen, Huiya Huang, Lingyun Yin, Zhen Xie, Michael Q Zhang.   

Abstract

Colorectal cancer is one of the most commonly diagnosed cancer types worldwide. Identification of the key regulators of the altered biological networks is crucial for understanding the complex molecular mechanisms of colorectal cancer. We proposed a gene module based approach to infer key miRNAs regulating the major gene network alterations in cancer tissues. By integrating gene differential expression and co-expression information with a protein-protein interaction network, the differential gene expression modules, which captured the major gene network changes, were identified for colorectal cancer. Then, several key miRNAs, which extensively regulate the gene modules, were inferred by analyzing their target gene enrichment in the modules. Among the inferred candidates, three miRNAs, miR-101, miR-124 and miR-139, are frequently down-regulated in colorectal cancers. The following computational and experimental analyses demonstrate that miR-139 can inhibit cell proliferation and cell cycle G1/S transition. A known oncogene ETS1, a key transcription factor in the gene module, was experimentally verified as a novel target of miR-139. miR-139 was found to be significantly down-regulated in early pathological cancer stages and its expression remained at very low levels in advanced stages. These results indicate that miR-139, inferred by the gene module based approach, should be a key tumor suppressor in early cancer development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25286864     DOI: 10.1039/c4mb00329b

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  5 in total

Review 1.  The recurrent architecture of tumour initiation, progression and drug sensitivity.

Authors:  Andrea Califano; Mariano J Alvarez
Journal:  Nat Rev Cancer       Date:  2016-12-15       Impact factor: 60.716

Review 2.  The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Authors:  Keiichi Koshizuka; Toyoyuki Hanazawa; Ichiro Fukumoto; Naoko Kikkawa; Yoshitaka Okamoto; Naohiko Seki
Journal:  J Hum Genet       Date:  2016-08-25       Impact factor: 3.172

Review 3.  Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs.

Authors:  María Antonia Lizarbe; Jorge Calle-Espinosa; Eva Fernández-Lizarbe; Sara Fernández-Lizarbe; Miguel Ángel Robles; Nieves Olmo; Javier Turnay
Journal:  Biomed Res Int       Date:  2017-05-10       Impact factor: 3.411

4.  Potential role of miR-139-5p in cancer diagnosis, prognosis and therapy.

Authors:  Ling-Li Huang; Ling-Wei Huang; Lei Wang; Ben-Ding Tong; Qing Wei; Xuan-Sheng Ding
Journal:  Oncol Lett       Date:  2017-06-08       Impact factor: 2.967

5.  A predictive analysis approach for paediatric and adult high-grade glioma: miRNAs and network insight.

Authors:  Anqi Liu; Hengyu Zhao; Banghao Sun; Xue Han; Danyang Zhou; Zhongqi Cui; Xiaoyu Ma; Jianan Zhang; Lijie Yuan
Journal:  Ann Transl Med       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.